Inhibition of insulin binding by concanavalin-A. 1980

W G Blackard, and E Small, and C Luderman

Prolonged incubation of IM-9 lymphoblastoid cells with concanavalin-A (Con-A) reduces insulin binding at concentrations of the lectin that neither agglutinate cells nor acutely inhibit insulin binding. Scatchard plot analysis suggested that Con-A treatment reduces insulin receptor number. Con-A-induced reduction in insulin binding resembles insulin "down regulation" in the time required for appearance and reversal of the binding alteration. The effect of Con-A on insulin binding was inhibited when the sugar alpha-methyl mannoside was incorporated into the incubation medium at the same time as Con-A. Even when the sugar was added after hours of Con-A exposure, the depressed insulin binding was reversed proportional to the reduction of Con-A binding to the cells by the sugar. This latter observation suggests steric hindrance as the mechanism for Con-A-induced reduction in insulin binding. The slow association rate of Con-A to the cells under the conditions of the experiments probably explains the prolonged exposure time to Con-A required for inhibition of insulin binding. Additional support for steric hindrance was observed in experiments in which insulin was "trapped" on cells after exposure to Con-A. Bivalent succinyl Con-A was only 10% as effective as the natural tetravalent lectin in reducing insulin binding. Cytoskeleton and protein synthesis inhibitors failed to alter the Con-A-induced reduction in insulin binding.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003571 Cytochalasin B A cytotoxic member of the CYTOCHALASINS. Phomin
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

W G Blackard, and E Small, and C Luderman
February 1992, The International journal of biochemistry,
W G Blackard, and E Small, and C Luderman
November 1977, Experimental cell research,
W G Blackard, and E Small, and C Luderman
March 1978, Biochemical pharmacology,
W G Blackard, and E Small, and C Luderman
June 1973, Journal of the Reticuloendothelial Society,
W G Blackard, and E Small, and C Luderman
January 1980, Archives of biochemistry and biophysics,
W G Blackard, and E Small, and C Luderman
January 1972, International journal of cancer,
W G Blackard, and E Small, and C Luderman
July 1978, Carbohydrate research,
Copied contents to your clipboard!